From e.e-owner@visionplants.org Fri Dec 21 10:31:51 2001 Return-Path: Received: from mta413.mail.yahoo.com (mta413.mail.yahoo.com [216.136.128.65]) by mail2.thuntek.net (8.11.6/8.11.0) with SMTP id fBLHVd473269 for ; Fri, 21 Dec 2001 10:31:41 -0700 (MST) (envelope-from e.e-owner@visionplants.org) Received: from mta413.mail.yahoo.com for valor@global-dialog.org; Dec 21 09:31:39 2001 -0800 X-Track: 2: 40 X-Yahoo-Forwarded: from eedonut@yahoo.com to valor@global-dialog.org Received: from 66.163.239.131 (EHLO visionplants.org) (66.163.239.131) by mta413.mail.yahoo.com with SMTP; 21 Dec 2001 09:31:38 -0800 (PST) Received: from smtp3.arnet.com.ar [200.45.191.14] by visionplants.org (SMTPD32-6.04) id A1D08A024A; Fri, 21 Dec 2001 12:30:56 -0500 Received: (qmail 20049 invoked from network); 21 Dec 2001 17:30:55 -0000 Received: from unknown (HELO oemcomputer) (200.45.132.24) by smtp3.arnet.com.ar with SMTP; 21 Dec 2001 17:30:54 -0000 Message-ID: <000401c18a44$e5cfe1e0$18842dc8@oemcomputer> From: "LacOv" To: References: <114.9a7c3b4.29542814@aol.com> Date: Fri, 21 Dec 2001 04:28:02 -0300 MIME-Version: 1.0 Content-Type: text/plain; charset="iso-8859-1" Content-Transfer-Encoding: 7bit X-Priority: 3 X-MSMail-Priority: Normal X-Mailer: Microsoft Outlook Express 5.50.4133.2400 X-MimeOLE: Produced By Microsoft MimeOLE V5.50.4133.2400 Subject: Re: EE: re: Syrian Rue Precedence: bulk Sender: e.e-owner@visionplants.org Reply-To: e.e@visionplants.org Status: R > > The diet thing is not an issue if you're talking about a single dose. See > Ott's experiments with this. He ate everything you're not supposed to and > never had a negative effect. > > Don't worry. Be happy. > > -Jeff But at first I would be careful- depending on your blood presure it could be dangerous, imho - most stuff listed as avoidable could be an exageration but others... - from deoxy site: Q. Please review the dietary restrictions that should be observed when a patient is receiving monoamine oxidase inhibitor (MAOI) therapy? R. Tyramine, is an amino acid which is found in various foods, and is an indirect sympathomimetic that can cause a hypertensive reaction in patients receiving MAOI therapy. Monoamine oxidase is found in the gastrointestinal tract and inactivates tyramine; when drugs prevent the catabolism of exogenous tyramine, this amino acid is absorbed and displaces norepinephrine from sympathetic nerve ending and epinephrine from the adrenal glands. If a sufficient amount of pressor amines are released, a patient may experience a severe occipital or temporal headache, diaphoresis, mydriasis, nuchal rigidity, palpitations, and the elevation of both diastolic and systolic blood pressure may ensue (Anon, 1989; Da Prada et al, 1988; Brown & Bryant, 1988). On rare occasions, cardiac arrhythmias, cardiac failure, and intracerebral hemorrhage have developed in patients receiving MAOI therapy that did not observe dietary restrictions (Brown & Bryant, 1988). Therefore, dietary restrictions are required for patients receiving MAOIs. Extensive dietary restrictions previously published were collected over a decade ago and due to changes in food processing and more reliable analytical methods, new recommendations have been published (Anon, 1989; McCabe, 1986). The tyramine content of foods varies greatly due to the differences in processing, fermentation, ripening, degradation, or incidental contamination. Many foods contain small amounts of tyramine and the formation of large quantities of tyramine have been reported if products were aged, fermented, or left to spoil. Because the sequela from tyramine and MAOIs is dose-related, reactions can be minimized without total abstinence from tyramine-containing foods. Approximately 10 to 25 mg of tyramine is required for a severe reaction compared to 6 to 10 mg for a mild reaction. Foods that normally contain low amounts of tyramine may become a risk if unusually large quantities are consumed or if spoilage has occurred (McCabe, 1986). Three lists were compiled (foods to avoid, foods that may used in small quantities, and foods with insufficient evidence to restrict) to minimized the strict dietary restrictions that were previously used and improve compliance and safety of MAOI therapy. The foods to avoid list consists of foods with sufficient tyramine (in small or usual serving sizes) that would create a dangerous elevation in blood pressure and therefore should be avoided (McCabe, 1986)